Research activity per year

Personal profile


Ischaemic heart disease: diabetic heart disease; VTE disease 

Main research areas

Previous research: Genetics and immunology in Type 1 diabetes. DMSc in this subject 2005.  

Non-commercial : Effects of liraglutide in patients with stable coronary disease - focus on both heart and metabolic parameters.

Company-initated studies on VTE (Bayer AS) and diabetic medication in heart disease (Bayer, Novartis)  

Current research

Currently I am involved in studies related to the metabolic (endocrine) effects and effect on heart function of liraglutide in patients with stable coronary disease.

Commercial studies are related to long term treatment with rivaroxaban in patients with  VTE (Bayer AS), effects of an GLP-1 agonist in patients with stable coronary disease (GSK)

Potential conflicts of interest

Not stockholder in any companies involved in production of medical products.

Have performed company sponsored  studies for Bayer AS, Novartis, GSK.


Dive into the research topics where Ole Peter Kristiansen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or